[Marcumarized patient must have surgery. Playing it safe with low molecular weight heparin bridging].
出版信息
MMW Fortschr Med. 2005 Jun 2;147(22):51.
PMID:15977637
Abstract
摘要
相似文献
1
[Marcumarized patient must have surgery. Playing it safe with low molecular weight heparin bridging].
MMW Fortschr Med. 2005 Jun 2;147(22):51.
2
[Is anticoagulation with heparins in phenprocoumon treated patients safe during operations?].[苯丙香豆素治疗的患者在手术期间使用肝素进行抗凝是否安全？]
Dtsch Med Wochenschr. 2002 Nov 2;127(44):2345. doi: 10.1055/s-2002-35189.
3
Perioperative bridging therapy for the at-risk patient on chronic anticoagulation.针对接受长期抗凝治疗的高危患者的围手术期桥接治疗。
Dis Mon. 2005 Feb-Mar;51(2-3):183-93. doi: 10.1016/j.disamonth.2005.03.014.
4
[Anticoagulation in patients with heart valve replacement in pregnancy].[妊娠期间心脏瓣膜置换患者的抗凝治疗]
Z Kardiol. 1998;87 Suppl 4:63-7.
5
[Discontinuing oral anticoagulation for elective surgical interventions].
Praxis (Bern 1994). 2011 Nov 16;100(23):1387-92; quiz 1393-5. doi: 10.1024/1661-8157/a000724.
6
How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.测定抗Xa因子活性以指导依诺肝素桥接治疗的作用有多大？一项试点研究。
Thromb Haemost. 2009 Feb;101(2):325-32.
7
Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?需要手术的长期抗凝患者：低分子量肝素真的可以用于“桥接”患者而非静脉使用普通肝素吗？
Catheter Cardiovasc Interv. 2009 Jul 1;74 Suppl 1:S17-21. doi: 10.1002/ccd.22000.
8
[Are there guidelines for performance of coloscopy during drug anticoagulation?].
Dtsch Med Wochenschr. 2003 Oct 31;128(44):2333. doi: 10.1055/s-2003-43182.
9
[Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].[围手术期使用依诺肝素桥接治疗。779例患者的前瞻性BRAVE注册研究结果]
Med Klin (Munich). 2007 Oct 15;102(10):809-15. doi: 10.1007/s00063-007-1098-0.
10
[Value of molecular markers for administration of anticoagulant therapy after heart valve replacement].[心脏瓣膜置换术后抗凝治疗中分子标志物的价值]
Z Kardiol. 1998;87 Suppl 4:42-5.
Zotero 插件